SPR Therapeutics – Medical Alley Association

Real-world Study of SPRINT 60-day Peripheral Nerve Stimulation (PNS) Corroborates Published Clinical Study Results

CLEVELAND, May 06, 2022 (GLOBE NEWSWIRE) — SPR Therapeutics announced the publication of a study that evaluated the real-world impact of 60-day peripheral nerve stimulation (PNS) in the management of chronic pain. To investigate if this short-term treatment could provide long-term relief in a real-world setting, a cross-sectional survey was conducted of patients who had […]

In the Know: Healthcare News for October 25, 2021

HistoSonics Receives FDA “Breakthrough Device Designation” for Novel Sonic Beam Therapy Abilitech Medical Raises $2.9M to Expand Exoskeleton Technology SPR Therapeutics Scores $37M for Pain Relief Tool and Other Digital Health Fundings Washington’s Proliance Surgeons and Minnesota’s Revo Health Strike Blockbuster Partnership Nuwellis Selected as a Recipient of the Governor’s International Trade Award Women in […]

FDA Clearance of an Expanded Indication for the SPRINT® PNS System Now Enables Treatment in Areas of the Head, Neck, and Torso

CLEVELAND, Ohio (Oct. 19, 2021) – SPR Therapeutics® has obtained clearance from the U.S. Food and Drug Administration (FDA) of a broader indication for use for its SPRINT Peripheral Nerve Stimulation (PNS) System. Prior clearance limited use of the SPRINT PNS System to the back and extremities, but the new indication allows the device to be used […]

SPR Therapeutics Expands U.S. Commercial Team Amid Record-Breaking Growth

Cleveland, Ohio (October 18, 2021) – SPR Therapeutics, a private medical device company focused on providing patients with pain relief without opioids or surgery, announced today it has raised $37 million in an oversubscribed Series D growth equity financing. The investment will be used to accelerate the rapidly growing commercial uptake of its FDA-cleared SPRINT® Peripheral Nerve […]

Multi-Center Study of SPRINT® PNS System for Chronic Low Back Pain Demonstrates Clinically Significant Improvements in Pain and Quality of Life

CLEVELAND, July 12, 2021 – In the largest, most rigorous study to date using the SPRINT® PNS System for chronic axial low back pain (LBP), patients that failed to find relief from at least two different prior LBP treatments (e.g., opioids, over-the-counter analgesics, physical therapy), were treated with the SPRINT PNS System targeting the lumbar medial […]

For the Record with Mark Stultz, SVP of Market Development, SPR Therapeutics

Mark has been actively involved in health care and medical device market development for over 25 years, having held senior positions at both large and emerging medical device companies spanning multiple disease states and technologies. Much of Mark’s past work has involved global market development for implantable product lines, with nearly 20 years spent specifically […]

Multi-center Study Demonstrates Significant Reductions in Postoperative Pain and Opioid Use Following Peripheral Nerve Stimulation Treatment

Cleveland, Ohio- April 26, 2021- Results of a multicenter trial recently published in Anesthesiology, the official peer-reviewed journal of the American Society of Anesthesiologists,demonstrated significant reductions in postoperative opioid use and pain following percutaneous peripheral nerve stimulation (PNS) compared to placebo. Participants undergoing painful orthopedic surgical procedures such as rotator cuff repair were randomized to receive PNS […]

Researchers Unveil a New Theory Explaining Long-Term Pain Relief

Stimulation of peripheral nerves warrants consideration early in the care continuum. Cleveland, Ohio- March 15, 2021- A novel theory recently published in the Journal of Pain Research proposes mechanisms by which a 60-day treatment using percutaneous peripheral nerve stimulation (PNS) may recondition the central nervous system (CNS) to restore normal pain processing and provide long-term pain relief for […]

SPRINT® PNS System Demonstrates the Important Role of the Multifidus in Treating Recurrent Low Back Pain Following RFA

CLEVELAND, March 02, 2021 — SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, announced publication of clinical data evaluating the impact of percutaneous peripheral nerve stimulation (PNS) for patients with recurrent low back pain who underwent a radiofrequency ablation (RFA) procedure at least six months prior. The study, published in Pain Medicine, evaluated patients who […]

In The Know: Healthcare News for February 1, 2021

Kindeva Appoints Shawn Cavanagh to Board of Directors SPR Therapeutics, Inc. Appoints Josh Boggs, PhD, As Chief Scientific Officer Smiths Medical Announces Launch of Portex® EchoGlo® Peripheral Nerve Block Portfolio Humanetics Corporation Receives Funding From Department of Defense to Test Drug Against COVID-19 Celcuity Announces Breast Cancer Clinical Trial Collaboration with Sarah Cannon and Pfizer […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER